Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-054610
Filing Date
2021-04-23
Accepted
2021-04-23 21:14:14
Documents
1
Period of Report
2021-04-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2113912-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2113912-1_4seq1.xml 4 3985
  Complete submission text file 0001104659-21-054610.txt   5485
Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Kulkarni Samarth (Reporting) CIK: 0001682019 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 21851188

Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)